Speech-Language Pathologists in Gouverneur, NY Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Ms. Erin Ayen Moon, M.S. ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Gleason St, Gouverneur, NY 13642 Phone: 315-287-2260 Fax: 315-287-2410 |
Haley Elizabeth Gregory, MS, ED CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Gouverneur Elementary School, 111 Gleason St, Gouverneur, NY 13642 Phone: 315-287-2260 |
Emily Murphy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Gleason St, Gouverneur, NY 13642 Phone: 315-287-2260 |
Brooke Richardson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Gleason St, Gouverneur, NY 13642 Phone: 315-528-8740 |
News Archive
First Edition: November 7, 2011
Today's early morning highlights from the major news organizations, including reports on venture capitalists' new interest in companies that can curb health costs and concerns among states on implementing the federal health law.
New therapy for multiple sclerosis sufferers
Serono and IVAX Corporation have announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).
Sudan categorically rejects allegations of civilian attacks by SAF
Sudan categorically rejects the allegation in the statement issued by the White House and Susan Rice that a children's school was bombed by the Sudan Armed Forces (SAF).
Study offers a promising blood test for depression, bipolar disorder
Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime. While current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine researchers sheds new light on the biological basis of mood disorders, and offers a promising blood test aimed at a precision medicine approach to treatment.
Breast cancer pilot study: Patients benefit from treatments guided by molecular profiling
The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute, Translational Drug Development and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling.
› Verified 8 days ago
Physical Therapists
Optometrists
Speech-Language Pathologists
Occupational Therapists
Chiropractors